BDMD Baird Medical Investment Holdings Ltd - Ordinary Share
NASDAQ · Health Care · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Jul 27, 2026
$0.75
· of 52w range
· above low
· to high
$0.6652w low
$3.7052w high
Market Cap
$23M
P/E
-0.8
EPS
$-0.98
Revenue
$23M
your badges
52W Range
$1–$4
Analyst Rating
·
Price Target
$4
P/E
-0.8
ROE
-76.8%
Net Profit Margin
-121.0%
Your badge strip is empty — pin a metric anywhere on this page.
BDMD Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$0.75
Market Cap
$23M
P/E
-0.8
EPS
$-0.98
Revenue
$23M
ROE
-76.8%
Debt/Equity
0.3
52W Range
$1–$4
BDMD Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$23M2022-12-31 → 2025-12-31
EPS$-0.982022-12-31 → 2025-12-31
Free Cash Flow$-1M2024-12-31 → 2025-12-31
Net margin-121.0%2024-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | BDMD | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -0.8 | · | · | · | |
| P/S | 1.0 | · | · | · | |
| P/B | 0.7 | · | · | · | |
| EV / EBITDA | -1.2 | · | · | · | |
| Price / FCF | -16.7 | · | · | · | |
| Price / Cash Flow | -17.2 | · | · | · | |
| EV / Revenue | 1.4 | · | · | · | |
| EV / FCF | -22.8 | · | · | · | |
| Price / Tangible Book | 0.7 | · | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | BDMD | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Gross Margin | 83.8% | · | · | · | |
| Operating Margin | -113.7% | · | · | · | |
| EBITDA Margin | -113.7% | · | · | · | |
| Pretax Margin | -117.0% | · | · | · | |
| Net Profit Margin | -121.0% | · | · | · | |
| ROA | -37.0% | · | · | · | |
| ROE | -76.8% | · | · | · | |
| ROIC | -66.8% | · | · | · |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | BDMD | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Debt / Equity | 0.3 | · | · | · | |
| Current Ratio | 1.7 | · | · | · | |
| Quick Ratio | 1.3 | · | · | · | |
| Long-Term Debt / Equity | 0.2 | · | · | · |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | BDMD | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.3 | · | · | · | |
| Inventory Turnover | 3.1 | · | · | · | |
| Receivables Turnover | 0.5 | · | · | · | |
| Revenue / Employee | ≈$154.4K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | $23M | $37M | $31M | $35M | |
| Cost of Revenue | $4M | $4M | $4M | $7M | |
| Gross Profit | $19M | $33M | $27M | $28M | |
| R&D Expense | $20M | $6M | $4M | $4M | |
| SG&A Expense | $14M | $7M | $9M | $7M | |
| Operating Expenses | $45M | $17M | $15M | $14M | |
| Operating Income | $-26M | $15M | $12M | $14M | |
| Interest Income | · | $393 | $1.6K | $8.6K | |
| Other Non-op | $-100.2K | $-651.7K | $-10.2K | $-194.6K | |
| Pretax Income | $-26M | $14M | $12M | $15M | |
| Income Tax | $1M | $1M | $2M | $2M | |
| Net Income | $-27M | $12M | $11M | $13M | |
| EPS (Basic) | $-0.98 | $0.57 | $0.51 | $0.49 | |
| EPS (Diluted) | $-0.98 | $0.57 | $0.51 | $0.49 | |
| Shares (Basic) | 27,792,704 | 21,826,549 | 20,588,236 | 25,555,096 | |
| Shares (Diluted) | 27,792,704 | 21,826,549 | 20,588,236 | 25,555,096 | |
| EBITDA | $-26M | $15M | · | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $178.3K | $3M | $2M | · | |
| Receivables | $43M | $47M | $31M | · | |
| Inventory | $1M | $1M | $1M | · | |
| Prepaid Expense | $11M | $10M | $6M | · | |
| Current Assets | $55M | $61M | $40M | · | |
| PP&E (Net) | $6M | $7M | $6M | · | |
| PP&E (Gross) | $12M | $12M | $10M | · | |
| Accum. Depreciation | $6M | $5M | $4M | · | |
| Goodwill | $60.3K | $57.8K | $59.4K | · | |
| Intangibles | $8.6K | $16.5K | $25.5K | · | |
| Total Assets | $70M | $78M | $57M | · | |
| Accounts Payable | $2M | $1M | $550.2K | · | |
| Current Liabilities | $32M | $35M | $19M | · | |
| Capital Leases | $27.6K | $136.7K | $412.1K | · | |
| Total Liabilities | $38M | $38M | $21M | · | |
| Long-term Debt | $9M | $4M | $2M | · | |
| Total Debt | $9M | $4M | · | · | |
| Common Stock | $3.1K | $2.6K | $2.6K | · | |
| Paid-in Capital | $29M | $11M | $19M | · | |
| Retained Earnings | $-515.4K | $27M | $14M | · | |
| AOCI | $-1M | $-3M | $-2M | · | |
| Stockholders' Equity | $31M | $40M | $36M | · | |
| Liabilities + Equity | $70M | $78M | $57M | · | |
| Shares Outstanding | 30,752,370 | 25,555,096 | 29,411,765 | · |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| D&A | $1M | $1M | $1M | $916.1K | |
| Stock-based Comp | $17M | · | · | · | |
| Deferred Tax | $-53.5K | $32.8K | $-542.0K | $-143.3K | |
| Amort. of Intangibles | $8.4K | $8.4K | $22.6K | $53.5K | |
| Operating Cash Flow | $-1M | $-6M | $-1M | $486.0K | |
| CapEx | $42.3K | $3M | $3M | $6M | |
| Investing Cash Flow | $-42.3K | $-2M | $-3M | $-6M | |
| Debt Issued | $6M | $3M | $3M | · | |
| Net Debt Issued | $4M | $2M | · | · | |
| Financing Cash Flow | $-1M | $10M | $3M | $4M | |
| Net Change in Cash | $-2M | $1M | $-200.4K | $-1M | |
| Taxes Paid | $836.6K | $2M | $3M | $1M | |
| Free Cash Flow | $-1M | $-9M | · | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Gross Margin | 83.8% | 88.2% | · | · | |
| Operating Margin | -113.7% | 41.3% | · | · | |
| Net Margin | -121.0% | 34.0% | · | · | |
| Pretax Margin | -117.0% | 38.0% | · | · | |
| EBITDA Margin | -113.7% | 41.3% | · | · | |
| ROA | -37.0% | 18.7% | · | · | |
| ROE | -76.8% | 33.4% | · | · | |
| ROIC | -66.8% | 31.1% | · | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | 1.7 | 1.8 | · | · | |
| Quick Ratio | 1.3 | 1.4 | · | · | |
| Debt / Equity | 0.3 | 0.1 | · | · | |
| LT Debt / Equity | 0.2 | 0.1 | · | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.6 | · | · | |
| Inventory Turnover | 3.1 | 3.6 | · | · | |
| Receivables Turnover | 0.5 | 1.0 | · | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Book Value / Share | $1.02 | · | · | · | |
| Revenue / Share | $0.81 | $1.45 | · | · | |
| Cash Flow / Share | $-0.05 | $-0.25 | · | · | |
| Cash / Share | $0.01 | · | · | · | |
| EPS (TTM) | $-0.98 | $0.57 | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue TTM | $23M | $37M | · | · | |
| Net Income TTM | $-27M | $12M | · | · | |
| Market Cap | $42M | · | · | · | |
| Enterprise Value | $50M | · | · | · | |
| P/E | -1.4 | 13.3 | · | · | |
| P/S | 1.9 | · | · | · | |
| P/B | 1.3 | · | · | · | |
| P / Tangible Book | 1.3 | · | · | · | |
| P / Cash Flow | -31.1 | · | · | · | |
| P / FCF | -30.2 | · | · | · | |
| EV / EBITDA | -2.0 | · | · | · | |
| EV / FCF | -36.3 | · | · | · | |
| EV / Revenue | 2.2 | · | · | · | |
| Earnings Yield | -72.1% | 7.5% | · | · |
No quarterly filings for BDMD
We don't have SEC filings for this ticker yet.
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | $23M | $37M | $31M | $35M |
| Gross Margin % | 83.8% | 88.2% | · | · |
| Operating Margin % | -113.7% | 41.3% | · | · |
| Net Income | $-27M | $12M | $11M | $13M |
| Diluted EPS | $-0.98 | $0.57 | $0.51 | $0.49 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Debt / Equity | 0.3 | 0.1 | · | · |
| Current Ratio | 1.7 | 1.8 | · | · |
| Quick Ratio | 1.3 | 1.4 | · | · |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | $-1M | $-9M | · | · |
Institutional owners (13F) 10 filers · $363K total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
10
Value held
$363K
New positions
4
Exited positions
2
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 4 (+2 vs prior Q) | 2 (0 vs prior Q) | 2 (+1 vs prior Q) | 3 (+2 vs prior Q) | -21K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| UBS Group AG | $67,490 | 58,687 | 18.60% | Shares |
| TWO SIGMA INVESTMENTS, LP | $63,825 | 55,500 | 17.59% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $63,677 | 55,371 | 17.55% | Shares |
| CITADEL ADVISORS LLC | $63,129 | 54,895 | 17.40% | Shares |
| JANE STREET GROUP, LLC | $36,310 | 31,574 | 10.01% | Shares |
| NATIONAL BANK OF CANADA /FI/ | $32,757 | 28,484 | 9.03% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $22,535 | 19,596 | 6.21% | Shares |
| XTX Topco Ltd | $12,846 | 11,170 | 3.54% | Shares |
| WOLVERINE ASSET MANAGEMENT LLC | $236 | 205 | 0.07% | Shares |
| Caitong International Asset Management Co., Ltd | $5 | 4 | 0.00% | Shares |
BDMD Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
12-Month Price Target
1 analysts · 2026-10-04Mean target $4.00 +432.6%
Low$4.00
Mean$4.00
High$4.00
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 20-F/A filed Jul 27, 2026